AI-Designed Bacteriophage Cocktail Administered to Patient Under Compassionate Use

Radical Numerics announced that it has administered a therapeutic cocktail of bacteriophages, designed by its Omnii-1 AI system, to a human patient under a compassionate-use agreement. The phages were engineered to attack the specific antibiotic-resistant bacteria isolated from the patient, and in laboratory assays they eradicated the pathogen. The treatment moves AI-designed phage therapy from bench to bedside, although the firm withheld any data on the patient’s response, emphasizing privacy and the preliminary nature of a single case.

The report does not specify the infection type, though the model was evaluated for predicting activity against Pseudomonas aeruginosa. Radical Numerics stresses that this milestone does not prove safety or efficacy and hopes the approach will eventually enable personalized anti-bacterial therapies. Antibiotic resistance remains a growing global health threat, making such advances noteworthy.